NCT05430841View on ClinicalTrials.gov

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Gastric CancerPancreatic CancerLiver Cancer
Interventions
DIAGNOSTIC_TEST

18F-FDG, 18F-AlF-FAPI PET/CT

Each subject receives a single intravenous injection of 18F-FDG and 18F-AlF-FAPI, and undergo PET/CT imaging within the specified time.

Trial Locations (1)

361000

The First affiliated hospital of xiamen university, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER